Меню
Идёт набор NCT07414719

Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.

Без фазы С лечением Middle School and High School Students

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: HPV animation.
Кому может быть актуально
Состояния в реестре: Middle School and High School Students. Базовые параметры: 11 лет — 17 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Prospective, Randomized, Cluster-controlled, Multicenter Study to Evaluate the Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.

Обзор

Human papillomaviruses (HPV) are very common contagious viruses: approximately 70% of men and women will be infected during their lifetime. Vaccination, recommended since 2007 for girls and since 2021 for all young people aged 11 to 14 (with catch-up vaccination possible up to age 26), remains insufficiently followed. Today, only 40.7% of adolescents are vaccinated in France, and the Auvergne Rhône Alpes region remains below the targets (47.5% for girls and 12.3% for boys). This is still far from the national target of 80% vaccination coverage by 2030, while 6,400 new cases of HPV-related cancers are reported each year. The PIMCOP regional study aims to assess the impact of a primary prevention intervention, co-developed with stakeholders and implemented in middle and high schools, on the HPV vaccination rate at 6 months among 11-17 year olds.

Вмешательства

  • Поведенческое HPV animation
    This presentation will enable young people to gather key information about HPV: - What is it? - How is it transmitted? - Who is affected? - What are the possible consequences? - How can you protect yourself? To this end, it was decided to hold a 1.5-hour presentation for 9th grade classes in middle school and 12th grade classes in high school. This presentation consists of a discussion with the students about the five key pieces of information mentioned above, followed by a game to find the loca

Первичные конечные точки

  • Vaccination [Срок оценки: Month 6]
Вторичные конечные точки (3)
  • health literacy level [Срок оценки: inclusion (Day 0), month 6]
  • levels of knowledge about HPV-related risks and other cancer risk factors [Срок оценки: inclusion (Day 0), month 6]
  • acceptability [Срок оценки: At the end of the intervention, maximum Day 5]

Критерии участия

Inclusion Criteria for children :

  • Girl or boy, student at a public school participating in the study
  • Aged 11 to 17
  • Having received an information sheet about the study and having signed a declaration of non-objection
  • Whose parents have also received an information sheet and have not expressed their non-objection
  • Able to read, write, and understand French
  • Affiliated with the SS or equivalent

Exclusion Criteria for children:

  • children protected by the law

Inclusion Criteria for teachers :

  • Male or female, teacher at a public school participating in the study and supervising a participating class
  • Aged 18 or over
  • Having received an information sheet about the study and not having expressed their opposition
  • Able to read, write, and understand French
  • Affiliated with the SS or equivalent

Exclusion Criteria for teachers :

\- Person specially protected by law

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Профилактика

Центры проведения

Франция · 1 центр
  • Lycée BELTRAME — Saint-Priest

Идентификаторы

NCT: NCT07414719 · PIMCOP

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗